Trials / Conditions / Strongyloides Stercoralis Infection

Strongyloides Stercoralis Infection

10 registered clinical trials studyying Strongyloides Stercoralis Infection — 2 currently recruiting.

Status	Trial	Sponsor	Phase
Recruiting	Risk Assessment of Community Spread of Multiple Endemic Infectious Diseases in a One Health Perspective NCT07358910	Institut Pasteur du Cambodge	—
Completed	Strongyloides Stercoralis Public Health Control in Rwanda NCT07009613	IRCCS Sacro Cuore Don Calabria di Negrar	—
Completed	Efficacy and Safety of Emodepside in Adults Infected With Strongyloidiasis Stercoralis NCT06373835	Swiss Tropical & Public Health Institute	Phase 2
Not Yet Recruiting	Preliminary Evaluation of Two Rapid Diagnostic Test Prototypes for Strongyloides Stercoralis Infection NCT06368609	IRCCS Sacro Cuore Don Calabria di Negrar	N/A
Completed	The SsRI/NIE Recombinant Antigen ELISA for the Follow up of Patients Infected by Strongyloides Stercoralis NCT06308705	IRCCS Sacro Cuore Don Calabria di Negrar	N/A
Completed	Efficacy and Safety of Moxidectin Versus Ivermectin Against Strongyloides Stercoralis NCT04848688	Jennifer Keiser	Phase 3
Completed	Evaluation of Strongyloidiasis in Ecuador: a fieLd Laboratory Accuracy Study NCT04999774	IRCCS Sacro Cuore Don Calabria di Negrar	—
Completed	Efficacy, Safety, and PK of Ascending Dosages of Moxidectin Versus Ivermectin Against Strongyloides Stercorali NCT04056325	Jennifer Keiser	Phase 2 / Phase 3
Terminated	Treatment of Strongyloides Infection NCT03605758	Albert Einstein College of Medicine	Phase 3
Unknown	Management of Soil-transmitted Helminthiasis and Strongyloidiasis NCT01308268	Universidad Nacional de Salta	N/A